<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03782961</url>
  </required_header>
  <id_info>
    <org_study_id>FE4 - HIDRAFEMME - PA - 010</org_study_id>
    <nct_id>NCT03782961</nct_id>
  </id_info>
  <brief_title>Evaluation of Viscosity of a Vaginal Moisturizer</brief_title>
  <official_title>Evaluation of Perceived Effectiveness to Evaluate Viscosity of a Vaginal Moisturizer in Menopaused Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Farmoquimica S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Farmoquimica S.A.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the perception of viscosity of a vaginal moisturizer in postmenopausal women&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A unicentric, blind, non-comparative clinical study to prove the perceived efficacy of the&#xD;
      research product.&#xD;
&#xD;
      It will be necessary 33 female research participants, aged between 45 and 70 years menopause&#xD;
      with complaint of vaginal dryness.&#xD;
&#xD;
      The participant will remain in the study for one day, making use of the research product in&#xD;
      the Research Center.&#xD;
&#xD;
      Participants will be divided into 2 groups so that each group observes the viscosity (flow)&#xD;
      of the test product in a different anatomical position (lying down and standing) immediately&#xD;
      after application of the product, after 15 and 30 minutes.&#xD;
&#xD;
      Participants will respond to a subjective assessment using a standardized questionnaire to&#xD;
      capture possible feelings of discomfort during the study.&#xD;
&#xD;
      A gynecologist will be available to monitor the participants throughout the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">January 14, 2019</start_date>
  <completion_date type="Anticipated">January 25, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 25, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate subjectively the perceived viscosity change</measure>
    <time_frame>Immediately after application, 15 and 30 minutes after application</time_frame>
    <description>Perceived viscosity change of the research product from the point of view of the target public under normal conditions of use through a questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">33</enrollment>
  <condition>Vaginal Dryness</condition>
  <condition>Menopausal Women</condition>
  <arm_group>
    <arm_group_label>Stand up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After application of the product (sodium lactate and combination of polymers) will remain standing for 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lying down</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After application of the product (sodium lactate and combination of polymers) remained lying down with the legs stretched for 30 minutes;</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sodium lactate and combination of polymers</intervention_name>
    <description>sodium lactate and combination of polymers (polycarbophil, carbomer and PVM / MA copolymer)</description>
    <arm_group_label>Lying down</arm_group_label>
    <arm_group_label>Stand up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Menopausal participants for at least 6 months;&#xD;
&#xD;
          -  Participants with complaints of vaginal dryness;&#xD;
&#xD;
          -  Skin integrity in the region of product analysis;&#xD;
&#xD;
          -  Agreement to comply the procedures of the trial and attend the clinic on the days and&#xD;
             times determined for applications and / or evaluations;&#xD;
&#xD;
          -  Understanding, agreement and signing of the Informed Consent Term.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of anti-inflammatory / immunosuppressive / antihistamine drugs up to 3 weeks prior&#xD;
             to selection;&#xD;
&#xD;
          -  Pathologies and / or active skin lesions (local and / or disseminated) in the&#xD;
             evaluation area;&#xD;
&#xD;
          -  Immunosuppression by drugs or active diseases;&#xD;
&#xD;
          -  Decompensated endocrinopathies;&#xD;
&#xD;
          -  Relevant clinical history or current evidence of alcohol or other drug abuse;&#xD;
&#xD;
          -  known history or suspected intolerance to products of the same category;&#xD;
&#xD;
          -  Intense sun exposure up to 15 days before evaluation;&#xD;
&#xD;
          -  Gynecological treatment up to 4 weeks before evaluation;&#xD;
&#xD;
          -  Other conditions considered by the researcher to be reasonable for disqualification of&#xD;
             study participation.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 18, 2018</study_first_submitted>
  <study_first_submitted_qc>December 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2018</study_first_posted>
  <last_update_submitted>December 20, 2018</last_update_submitted>
  <last_update_submitted_qc>December 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

